Health ❯ Medicine ❯ Neurological Disorders ❯ Amyotrophic Lateral Sclerosis (ALS)

Relyvrio Treatment

ALS Drug Relyvrio Fails Key Clinical Trial, May Be Pulled from Market

Amylyx Pharmaceuticals to consult with FDA and ALS community after disappointing trial results; stock plunges over 83%.